Cancer treatment reports

Journal

Publication Venue For

  • 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial..  71:779-780. 1987
  • Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial..  71:773-774. 1987
  • Phase II evaluation of etoposide in refractory multiple myeloma: A Southeastern Cancer Study Group Trial.  70:801-802. 1986
  • Weekly mitoxantrone therapy for refractory multiple myeloma: A Southeastern Cancer Study Group trial.  70:669-670. 1986
  • Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: A Southeastern Cancer Study Group trial.  70:533-534. 1986
  • Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: A Southeastern Cancer Study Group trial.  70:427-428. 1986
  • Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: A Southeastern Cancer Study Group trial.  70:311-312. 1986
  • Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: A Southeastern Cancer Study Group trial.  70:267-270. 1986
  • High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: A Southeastern Cancer Study Group trial.  70:1229-1230. 1986
  • Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: A Southeastern Cancer Study Group trial.  70:1221-1223. 1986
  • Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: A Southeastern Cancer Study Group trial.  70:929-930. 1986
  • Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: A Southeastern Cancer Study Group trial.  69:1457-1458. 1985
  • Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: A phase II study of the southeastern cancer study group.  69:821-824. 1985
  • Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: A southeastern cancer study group trial.  69:725-726. 1985
  • Phase II evaluation of chlorozotocin in refractory multiple myeloma.  68:1409-1410. 1984
  • Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: A Southeastern Cancer Study Group Trial.  68:1517-1518. 1984
  • Mitoxantrone in malignant melanoma.  68:903-905. 1984
  • Treatment of metastatic sarcomas with mitoxantrone.  68:813-814. 1984
  • Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: A Southeastern Cancer Study Group trial.  68:929-930. 1984
  • Chemotherapy for advanced Hodgkin's disease: Conclusions from the Southeastern Cancer Study Group.  66:899-905. 1982
  • Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): A pilot study of the southeastern cancer study group.  66:199-200. 1982
  • Phase II trial of piperazinedione in malignant melanoma: A report by the Southeastern Cancer Study Group.  63:1367-1369. 1979
  • Treatment of refractory adult acute leukemia with 5-azacytidine plus β-2'-deoxythioguanosine.  63:209-210. 1979
  • BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.  61:1085-1096. 1977
  • Twice weekly 5-azacytidine infusion in disseminated metastatic cancer: A phase II study.  61:1675-1677. 1977
  • Southeastern cancer study group trials with nitrosoureas in Hodgkin's disease.  60:781-787. 1976
  • International Standard Serial Number (issn)

  • 0361-5960